TEVA Pharmaceutical Industries Ltd (TEVA)

Sector: Healthcare
Industry: Pharmaceutical Preparations
Country: Israel
Exchange: NYSE
Market cap: $162.42B
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Latest financial period: September 30, 2026
Filed with the SEC: November 3, 2026
Estimated earnings date: Not available
Profit #987 of 1422 companies
| | Sep 26 | Jun 26 | Mar 26 | Dec 25 |
|---|
| ROE/ROA | 29.8% | 27.4% | 32.4% | 29.2% |
Growth #727 of 1422 companies
Payout #1089 of 1422 companies
Safety #1203 of 1422 companies
Price #1257 of 1422 companies